In big Pharma news, GSK (GlaxoSmithKline) has vowed to manufacture and distribute low cost drugs to the world's poor, a variable shift from the monetarily inclined stigma that has plagued "Big Pharma." According to Guardian.co.uk, the new head of GlaxoSmithKline, Andrew Witty, has told the Guardian he will slash prices on all medicines in the poorest countries, give back profits to be spent on hospitals and clinics and – most ground-breaking of all – share knowledge about potential drugs that are currently protected by patents. How will this affect the marketing and distribution budgets of GSK? Will we see a rise in social awareness/social networking, etc as they embark on this change? Please share your thoughts.